Hasil Pencarian  ::  Simpan CSV :: Kembali

Hasil Pencarian

Ditemukan 153364 dokumen yang sesuai dengan query
cover
Yuri Nurdiantami
"Besarnya jumlah penderita hipertensi di dunia merupakan masalah yang patut diperhatikan. Walaupun penemuan obat antihipertensi sudah banyak dilakukan namun penurunan jumlah pasien tidak signifikan. Salah satu alternatif pengobatan hipertensi adalah penggunaan tanaman obat mengingat terdapat banyak masalah efek samping dari penggunaan obat konvensional. Tanaman obat yang digunakan sebagai antihipertensi bekerja dengan berbagai mekanisme, salah satunya adalah penghambatan angiotensin converting enzyme (ACE).
Tujuan penelitian ini adalah untuk mengetahui aktivitas penghambatan ACE dari tanaman obat Indonesia dan kandungan kimia dari tanaman tersebut. Berbagai penelitian mengenai penghambatan ACE telah dilakukan, namun belum terdapat penelitian mengenai aktivitas penghambatan ACE dari tanaman yang terdapat di Indonesia. Uji penghambatan aktivitas ACE dilakukan dengan menggunakan substrat Hipuril-L-Histidil-L-Leusin (HHL) dan metode spektrofotometri. Serbuk simplisia dimaserasi menggunakan etanol 80%.
Berdasarkan pengujian pada sepuluh tanaman, tiga ekstrak tanaman dengan aktivitas penghambatan yang baik adalah ekstrak dari daun Ocimum americanum L., buah Carissa carandas L., dan herba Mirabilis jalapa L. dengan nilai IC50 berturut-turut, 32,92 μg/mL; 33,36 μg/mL; dan 50,95 μg/mL. Ekstrak daun Ocimum americanum L. mengandung alkaloid, flavonoid, terpenoid, tanin, saponin dan antrakuinon. Ekstrak herba Mirabilis jalapa L. mengandung alkaloid, flavonoid, antrakuinon, tanin, dan terpenoid. Sedangkan ekstrak buah Carissa carandas L. mengandung glikosida, flavonoid dan terpenoid.

The large number of patients with hypertension in the world should be worried. Although the discovery of antihypertensive drugs has been done but the decline in the number of patients was not significant.. The use of medicinal plants for treating hypertension is common since there are problems with side effects from the conventional medicine. Medicinal plants used as antihypertensive work with a variety of mechanisms, one of which is the inhibition of angiotensin converting enzyme (ACE).
The purpose of this study was to determine the inhibitory activity of ACE from medicinal plants in Indonesia and chemical constituents of the plants. Test inhibition of ACE activity performed using substrate Hipuril-L-Histidil-L- Leucine (HHL) and spectrophotometric methods. Powdered crude drug was macerated using 80% ethanol.
Based on the testing of ten plants, three active extracts are Ocimum americanum L. leaves, Carissa carandas L. fruits, and Mirabilis jalapa L. herbaceous with IC50 values respectively 32.92 μg/mL, 33.36 μg /mL, and 50.95 μg/mL. Leaf extracts of Ocimum americanum L. contain alkaloids, flavonoids, terpenoids, tannins, saponins and anthraquinones. Herbaceous of Mirabilis jalapa L. contain alkaloids, flavonoids, terpenoids, tannins, and anthraquinones. While the fruit extracts of Carissa carandas L. contain glycosides, flavonoids and terpenoids.
"
Depok: Fakultas Farmasi Universitas Indonesia, 2013
S52541
UI - Skripsi Membership  Universitas Indonesia Library
cover
Sheila Noor Aisyah
"Indonesia adalah Negara yang kaya akan tanaman, namun banyak yang belum diketahui efek farmakologinya. Di antaranya, diduga ada yang memiliki efek hipotensif. Tanaman-tanaman tersebut diteliti efek penghambatan aktivitas Angiotensin Converting Enzyme (ACE) yang mana memiliki potensi sebagai hipotensif. ACE berperan sebagai regulator dalam sistem renin-angiotensinaldosteron (RAAS), yang mana ketika ACE diaktifkan, maka angiotensin I akan dikonversi menjadi angiotensin II, yang akan berperan sebagai vasokonstriktor. ACE juga dapat menonaktifkan bradikinin dan kallikrein, yang merupakan molekul vasodilator. Karena mekanisme kerja inilah, ACE dapat meningkatkan tekanan darah.
Penelitian ini bertujuan untuk menguji penghambatan aktivitas ACE oleh ekstrak etanol dari beberapa tanaman obat di Indonesia dan penapisan fitokimia pada ekstrak etanol dengan efek penghambatan aktivitas di atas 80%. Uji in-vitro penghambatan aktivitas ACE menggunakan substrat Hippuryl-Lhistidyl- L-leucine. Hasil menunjukkan bahwa ekstrak etanol buah Averrhoa carambola L dan daun Graptophyllum pictum memiliki nilai IC50 masing-masing 53,79 μg/mL dan 49,55 μg/mL. Golongan senyawa kimia yang terdapat pada ekstrak etanol buah Averrhoa carambola L adalah glikosida, flavonoid, dan saponin. Sedangkan ekstrak etanol daun Graptophyllum pictum mengandung glikosida, tanin, flavonoid, terpen, alkaloid, dan saponin. Hasil ini membuktikan bahwa daun Graptophyllum pictum memiliki potensi untuk menjadi bahan penelitian uji aktivitas ACE untuk ke depannya nanti.

Indonesia is rich in plants, but there are still unknown pharmacological effects of some of them. There are plants which presumably have a hypotensive effect. This plants were studied for its inhibiton effect of Angiotensin Converting Enzyme (ACE) that can lower blood pressure. ACE served as the regulator of the renin-angiotensin-aldosterone system, when ACE is activated, angiotensin I will be converted to angiotensin II, which will act as a vasoconstrictor. ACE can disable bradykinin and kallikrein, which are a vasodilator molecules. Because of that, ACE can increase blood pressure.
This research aimed to study the inhibition effect of ACE activity in ethanol extracts of some Indonesian medicinal plants and to do a phytochemical screening in ethanol extracts with inhibition activity rate above 80%. The in-vitro test of Inhibition Activity of ACE used Hippuryl-Lhistidyl- L-leucine. The result showed that the IC50 values for Averrhoa carambola L fruits and Graptophyllum pictum leaves are 53,79 μg/mL and 49,55 μg/mL. Averrhoa carambola L fruits contained glycosides, flavonoid, and saponins. While in Graptophyllum pictum leaves contained flavonoids, tannins, glycosides, terpenoids, alkaloids, dan saponins. These result shows that Graptophyllum pictum leaves have potentials to be a material for the ACE activity research in the future.
"
Depok: Fakultas Farmasi Universitas Indonesia, 2013
S46963
UI - Skripsi Membership  Universitas Indonesia Library
cover
Donny Lukmanto
"Hipertensi merupakan salah satu masalah vaskular dengan jumlah penderita yang terus meningkat setiap tahunnya. Inhibitor Angiotensin Cnverting Enzyme (ACE) merupakan salah satu obat pilihan dalam penatalaksanaan hipertensi modern yang dikembangkan dari produk alam. Selain pengobatan modern, juga dikenal pengobatan tradisional dengan menggunakan tanaman untuk mengobati hipertensi. Pada penelitian ini, 9 jenis tanaman yang telah digunakan secara turun temurun untuk mengobati hipertensi dipilih untuk diuji aktivitas inhibisi ACE. Tujuan penelitian ini adalah mengetahui aktivitas inhibisi ACE dari beberapa ekstrak tanaman uji dan mengetahui golongan kimia yang terkandung dalam ekstrak tanaman yang aktif menginhibisi ACE. Aktivitas inhibisi terhadap ACE yang diuji menggunakan metode in vitro dengan menggunakan substrat Hipuril- Histidil-Leusin (HHL) menunjukkan beberapa ekstrak tanaman berpotensi sebagai antihipertensi alamiah dengan ekstrak kulit batang nangka (Artocarpus heterophyllus) menunjukkan aktivitas inhibisi ACE paling baik dengan IC50 sebesar 5,73 μg/mL. Hasil uji penapisan fitokimia menunjukkan golongan kimia yang terkandung dalam ekstrak ini adalah alkaloid, glikosida, tanin, polifenol dan saponin. Hasil penelitian ini menunjukkan potensi beberapa tanaman sebagai sumber ACE inhibitor dan perlu diteliti lebih lanjut.

Hypertension is vascular problem with increasing number of patients every year. Angiotensin Converting Enzyme Inhibitor (ACEi) is recognized as drug of choice in modern hypertension therapy that developed from natural products. Futhermore, many plants in this world have been used as traditional antihypertensive agent, so we used this several traditionally antihypertensive plants as test subjects. Therefore, this research aims to determine ACE inhibition activity from several plants extract and determine phytochemical properties from active extract. ACE inhibitory activity is tested using in vitro methods showed some plant extracts have potential as a natural anti-hypertensive agent with stem bark extract of jackfruit (Artocarpus heterophyllus) showed the most active ACE inhibitory activity with IC50 of 5.73 μg/mL. Phytochemical screening test showed these extract contents are alkaloids, glycosides, tannins, polyphenols and saponins. These findings suggested that several plants might have potential as anti-hypertensive agent and need futher research."
Depok: Fakultas Farmasi Universitas Indonesia, 2013
S52568
UI - Skripsi Membership  Universitas Indonesia Library
cover
Abi Fauzan Akbar
"Hipertensi merupakan suatu penyakit vaskular yang memiliki prevalensi yang cukup tinggi di Indonesia, yaitu sebesar 6,8% menurut sumber Riskesdas tahun 2007. Pencarian obat-obatan dari produk alami untuk penatalaksanaan hipertensi modern terus dikembangkan hingga saat ini. Salah satu produk alami yang diduga memiliki khasiat antihipertensi adalah kulit batang nangka (Artocarpus heterophyllus) yang bekerja dengan menghambat Angiotensin Converting Enzyme (ACE). Penghambat ACE merupakan salah satu metode obat pilihan untuk penatalaksanaan hipertensi.
Tujuan dari penelitian ini adalah untuk memperoleh fraksi teraktif dari ekstrak kulit batang nangka serta mengetahui golongan senyawa kimia dari fraksi teraktif tersebut. Uji penghambatan aktivitas ACE dilakukan secara in-vitro dengan substrat HHL (Hippuryl-L-histidyl-L-leucine).
Hasil penelitian menunjukkan bahwa fraksi diklorometan dari ekstrak etanol kulit batang nangka merupakan fraksi teraktif dalam menghambat aktivitas ACE dengan nilai IC50 sebesar 0,76 μg/mL. Adapun golongan-golongan senyawa kimia yang terdapat pada fraksi diklorometan ekstrak etanol kulit batang nangka adalah flavonoid, tannin, alkaloid, terpenoid dan saponin. Hasil ini menunjukkan bahwa kulit batang nangka memiliki potensi untuk diteliti lebih lanjut kandungan senyawa yang terdapat didalamnya yang berperan dalam penghambatan ACE tersebut.

Hypertension is a vascular disease that has a high prevalence in Indonesia, reaching 6.8 % in 2007 according to Riskesdas. Search for medicines from natural products for management of hypertension continues to be developed to date. One of the natural products that suspected to have antihypertensive effects is stem bark of jackfruit (Artocarpus heterophyllus Lam), which works by inhibiting the Angiotensin Converting Enzyme (ACE). ACE inhibitor is one method of choice for the management of hypertension.
The purpose of this study is to obtain the most active fraction from the extract of jackfruit stem bark and to determine the chemical compounds of the most active fraction. ACE activity inhibition test were tested using in vitro method with HHL (Hippuryl-L-histidyl-L-leucine) as a substrate.
Results showed that the dichloromethane fraction from ethanol extract of jackfruit stem bark is the most active fractions in inhibiting ACE activity with IC50 value of 0,76 μg / mL. The constituents of chemical compounds contained in the dichloromethane fraction from ethanol extract of jackfruit stem bark are flavonoids, tannins, alkaloids, terpenoids and saponins. These results suggest that the stem bark of jackfruit has the potential to be further investigated by future studies to determine the compounds that plays a role in the inhibition of ACE."
Depok: Fakultas Farmasi Universitas Indonesia, 2014
S55891
UI - Skripsi Membership  Universitas Indonesia Library
cover
Joseph Stephen Rinandy
"Indonesia merupakan negara yang kaya akan tanaman obat. Tanaman obat tersebut dapat dimanfaatkan di dalam bidang kesehatan. Pemanfaatan tanaman obat tersebut salah satunya adalah sebagai pengobatan penyakit hipertensi. Hipertensi merupakan penyakit mendunia yang jumlah penderitanya meningkat sejak tahun 1980 hingga sekarang. Hipertensi merupakan penyakit pada pembuluh darah yang dapat memicu risiko faktor penyakit lain seperti stroke, gagal ginjal, kebutaan, kebocoran pembuluh darah, dan penurunan fungsi kognitif. Terapi melalui mekanisme penghambatan ACE bermanfaat untuk menurunkan tekanan darah dan dapat mengurangi morbiditas, mengurangi kematian akibat gagal jantung, dan menghambat keparahan diabetes nefropati. Pada penelitian ini, pengujian dilakukan berdasarkan pendekatan ilmiah untuk menentukan efek penghambatan aktivitas ACE dari beberapa tanaman obat di Indonesia. Pengukuran efek penghambatan aktivitas ACE dilakukan dengan menggunakan substrat hipuril-histidil-leusin (HHL) dengan metode secara in vitro. Hasil uji menunjukkan bahwa ekstrak biji Sesamum indicum L. memberikan nilai penghambatan ACE terbesar dengan nilai IC50 sebesar 30,44 µg/mL, namun penghambatannya lebih rendah dibandingkan dengan standar kaptopril (IC50 13,69 µg/mL). Hasil uji penapisan fitokimia dari ekstrak biji Sesamum indicum L. mengandung senyawa golongan alkaloid, glikosida, dan terpenoid. Berdasarkan penelitian ini, ekstrak biji Sesamum indicum L. memiliki potensi untuk dikembangkan sebagai inhibitor ACE untuk menemukan senyawa aktif biologi yang berperan dari ekstrak tersebut.

Indonesia is a country that has many medicinal plants which can be used as hypertension medicine. Hypertension cases has been increasing since 1980. Hypertension as a blood vascular disease can give another risk factors of diseases like stroke, kidney failure, blindness, rupture of blood vessel, and cognitive impairment. A therapy with ACE inhibition mechanism is a useful therapy to decrease blood pressure and gives another benefits to reduce morbidity, mortality by heart failure, and inhibit the progresiveness of diabetic nephropathy. One source of ACE inhibitors can be obtained from plants. In this research, the test is based on a scientific approach to determine inhibition activity effect of ACE from several medicinal plants in Indonesia. The measurement of the inhibition activity effect of ACE is done by using hippuryl-L-histidyl-L-leucine (HHL) as the substrate with in vitro method. The test results showed the inhibition activity effect of ACE from Sesamum indicum L. seed extract gives the largest value of ACE inhibition with IC50 values ​​of 30.44 µg/mL, but the inhibition value is lower than captopril as standard (IC50 13.69 µg/mL). The result of phytochemical screening in Sesamum indicum L. seed extract contains alkaloids, glycosides, and terpenoids.
"
Depok: Fakultas Farmasi Universitas Indonesia, 2013
S46472
UI - Skripsi Membership  Universitas Indonesia Library
cover
Annesya Shafira Amartya
"Apotek merupakan sarana pelayanan kesehatan yang berperan aktif untuk mewujudkan upaya kesehatan dengan memberikan informasi obat kepada masyarakat dan tenaga kesehatan lainnya. Tugas apoteker di apotek adalah memberikan informasi yang tepat untuk meningkatkan derajat kesehatan pasien. Salah satu penyakit yang membutuhkan kepatuhan dan taat minum obat adalah hipertensi. Hipertensi termasuk the silent killer karena sering tanpa gejala dan keluhan sehingga penderita tidak mengetahui dirinya mengalami hipertensi. Tujuan tugas khusus ini adalah untuk mengedukasi pasien mengenai penyakit hipertensi, gejala hipertensi, mengatasi penyakit hipertensi dengan terapi farmakologis dan non farmakologis, serta menyadarkan masyarakat untuk dapat mengatasi penyakit hipertensi dengan baik. Penyampaian edukasi dan promosi dapat dibantu dengan media kesehatan sebagai alat bantu edukasi. Salah satu media yang dapat digunakan adalah poster dan leaflet kesehatan. Metode yang dilakukan untuk pembuatan poster dan leaflet adalah melalui studi literatur mengenai pembuatan poster dan leaflet serta mengenai hipertensi dan pedoman pengobatan hipertensi.. Isi poster dan leaflet tersebut berupa gerakan yang bersifat persuasif untuk mengajak pasien menerapkan perilaku hidup sehat dengan memakan makanan bergizi seimbang, rutin olahraga, dan memeriksa kesehatan secara rutin untuk mendapatkan penanganan yang tepat. Informasi pada poster dan leaflet diakhiri dengan kalimat persuasif untuk meningkatkan kesadaran pembaca untuk menjaga tekanan darah agar tetap di dalam batas normal. Apabila pembaca adalah penderita hipertensi, diharapkan untuk meningkatkan kesadaran agar segera mengonsultasikan diri ke dokter dan menjalani pengobatan.

Pharmacy is a health service facility that has a role in giving information to patient and health workers. Pharmacist in pharmacy has a role in giving information to increasing patient's health status. One of a disease that should take a drug obediently and adherently is hypertension. Hypertension is the silent killer disease because it hasn't symptom and patients doesn't realize if they have hypertension disease. This paper aim to give education to patients about a definition, symptoms, curing by pharmacology and non-pharmacology, and prevent the complication of hypertension. Education can be deliver by using educational media. One of educational media that can use is poster and leaflet. Poster and leaflet is made by literature study about how to make educational media properly and about hypertension. A content of poster and media is a preventive and curative action to have living healthy behaviour by eating nutritional food, doing exercise, and doing medical check-up routinely. The information on the poster and leaflet ends with persuasive sentence to increase reader awareness to maintain blood tension. If the readers are patients with hypertension, readers should be more aware of their healthiness by doing consultation with the doctor and have a medication routinely."
Depok: Fakultas Farmasi Universitas ndonesia, 2022
PR-pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Siska Amanda Amadea
"ABSTRAK
Praktek kerja profesi di Apotek Kimia Farma Nomor 143 Depok Periode September Tahun 2017 bertujuan untuk memahami tugas dan tanggung jawab apoteker dalam pengelolaan apotek, serta melakukan praktek pelayanan kefarmasian sesuai dengan ketentuan perundang undangan dan etika yang berlaku, memiliki wawasan, pengetahuan, keterampilan, dan pengalaman praktis untuk melakukan praktek kefarmasian di apotek, memiliki gambaran nyata tentang permasalahan praktek kefarmasian serta mempelajari strategi dan kegiatan kegiatan yang dapat dilakukan dalam rangka pengembangan praktek kefarmasian. Praktek kerja profesi di Apotek Kimia Farma Nomor 143 dilakukan selama empat minggu dengan tugas khusus yaitu Pengkajian Resep Terapi Hipertensi di Apotek Kimia Farma Nomor 143 Depok. Tujuan dari tugas khusus ini adalah untuk mengkaji kelengkapan resep berdasarkan persyaratan administratif, kesesuaian farmasetik, dan pertimbangan klinis.

ABSTRACT
Internship at Kimia Farma Pharmacy No. 143 Depok Period September 2017 aims to understand the duties and responsibilities of pharmacists in pharmacy management, as well as to practice pharmaceutical services in accordance with applicable laws and ethics, have the insights, knowledge, skills, and practical experience to undertake pharmaceutical practices in pharmacies, have a real picture about pharmaceutical practice issues and learn the strategies and activities that can be undertaken in the development of pharmaceutical practice. Internship at Kimia Farma Pharmacy No. 143 was conducted for four weeks with special assignment Assessment of Hypertension Therapy Prescription at Kimia Farma Pharmacy No. 143 Depok. The purpose of this special assignment is to assess the completeness of prescriptions based on administrative requirements, pharmaceutical conformity, and clinical considerations."
Depok: Fakultas Farmasi Universitas Indonesia, 2017
PR-Pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Ingrid Faustine
"Hipertensi merupakan penyakit penyerta yang paling umum ada pada penderita COVID-19. Faktor risiko seperti genetik, sosiodemografi, dan kondisi klinis awal diduga dapat memengaruhi kerentanan individu terhadap hipertensi dan COVID-19. Salah satu gen yang berhubungan dengan hipertensi adalah gen ACE. Penelitian ini bertujuan untuk mengkaji variasi genetik gen ACE dalam hubungannya dengan risiko kerentanan dan penanganan penyakit hipertensi dan COVID-19 menggunakan model populasi Palu-Sulawesi Tengah. Penelitian ini merupakan studi observasional dengan desain cross-sectional. Data faktor non-genetik diperoleh dari rekam medis dan kuesioner. Identifikasi variasi genetik dilakukan pada 4 lokasi pada gen ACE, yaitu rs1799752 (I/D) dengan metode PCR, dan rs4331 (A/G), rs4341 (G/C), dan rs4343 (G/A) dengan rhAmp SNP genotyping. Data faktor genetik dan non-genetik kemudian disusun menjadi model instrumen translasional. Studi melibatkan 136 subjek, dan analisis variasi genetik menunjukkan genotipe dominan untuk rs1799752 adalah II (50%), rs4331 adalah GG (51%), rs4341 adalah GG (100%), dan rs4343 adalah AA (65%). Varian alel D rs1799752, alel A rs4331, dan alel G rs4343 menunjukkan hubungan dengan kerentanan terhadap hipertensi, COVID-19, dan keparahan COVID-19. Analisis regresi menunjukkan bahwa jenis kelamin, usia, riwayat hipertensi, LDL, asam urat, glukosa darah, dan variasi genetik gen ACE adalah prediktor dalam menilai tingkat risiko hipertensi. Sementara itu, jenis kelamin, trigliserida, HDL, komorbiditas hipertensi, dan variasi genetik gen ACE adalah prediktor dalam menilai risiko terhadap kejadian COVID-19, sementara komorbiditas hipertensi, IMT, asam urat, dan variasi genetik gen ACE adalah prediktor dalam menilai risiko keparahan COVID-19. Asesmen prediksi instrumen translasional menunjukkan bahwa 31% dari kelompok hipertensi berisiko tinggi terhadap kejadian COVID-19 dan 46% memiliki berisiko sangat tinggi untuk mengalami keparahan yang lebih tinggi. Asesmen prediksi instrumen translasional hipertensi menunjukkan bahwa 22% subjek memiliki risiko sangat tinggi dan 23% diantaranya memerlukan penyesuaian pola terapi. Variasi gen ACE rs4331, rs1799752, dan rs4343, bersama dengan faktor risiko non-genetik, dapat digunakan sebagai prediktor untuk kejadian hipertensi, COVID-19, dan keparahan COVID-19. Variasi gen dan faktor non-genetik ini dapat dikembangkan menjadi model pengobatan presisi untuk mengevaluasi tingkat risiko dan penanganan individu terhadap hipertensi, COVID-19, dan keparahan COVID-19 di kalangan populasi Palu-Sulawesi Tengah secara translasional.

Hypertension is the most common comorbidity in COVID-19 sufferers. Risk factors such as genetics, sociodemographics, and initial clinical conditions are thought to influence an individual's susceptibility to hypertension and COVID-19. One of the genes associated with hypertension is the ACE gene. This study examines the ACE gene's genetic variation in summary with the risk of developing hypertension and COVID-19 using the Palu-Central Sulawesi population model. This research is an observational study with a cross-sectional design. Data on non-genetic factors were obtained from medical records and questionnaires. Identification of genetic variations was carried out at 4 locations in the ACE gene, namely rs1799752 (I/D) using the PCR method, rs4331 (A/G), rs4341 (G/C), and rs4343 (G/A) using rhAmp SNP genotyping. Data on genetic and non-genetic factors are then compiled into a translational instrument model. The study involved 136 subjects, and analysis of genetic variations showed that the dominant genotype for rs1799752 was II (50%), rs4331 was GG (51%), rs4341 was GG (100%), and rs4343 was AA (65%). The variant D allele rs1799753, A allele rs4331, and G allele rs4343 showed an association with susceptibility to hypertension, COVID-19, and severity of COVID-19. Regression analysis showed that gender, age, history of hypertension, LDL, uric acid, blood glucose, and genetic variations of the ACE gene were predictors in assessing the level of hypertension risk. Meanwhile, gender, triglycerides, HDL, comorbid hypertension, and genetic variations of the ACE gene are predictors in determining the risk of COVID-19. In contrast, comorbid hypertension, BMI, uric acid, and genetic variations of the ACE gene are predictors in assessing the risk of COVID-19 severity. -19. The translational instrument prediction assessment showed that 31% of the hypertension group were at high risk of experiencing COVID-19, and 46% were at very high risk of experiencing higher severity. The translational instrument prediction assessment for hypertension showed that 22% of subjects had a very high risk, and 23% of them required adjustment of therapy patterns. ACE gene variations rs4331, rs1799752, and rs4343, together with non-genetic risk factors, can be used as predictors for the incidence of hypertension, COVID-19, and severity of COVID-19. These gene variations and non-genetic factors can be developed into a precision medicine model to evaluate the risk level and individual treatment of hypertension, COVID-19, and the severity of COVID-19 among the Palu-Central Sulawesi population in a translational."
Depok: Fakultas Farmasi Universitas Indonesia, 2024
D-pdf
UI - Disertasi Membership  Universitas Indonesia Library
cover
Yusak Alfrets Porotuo
"ABSTRAK
Latar belakang. Hipertensi merupakan salah satu kondisi yang paling banyak
ditemukan pada pelayanan kesehatan primer yang dapat meningkatkan mortalitas dan
morbidita apabila tidak mendapatkan pengobatan yang tepat. Beberapa penelitian
menunjukkan respon penurunan tekanandarah pada ras kulit hitam berbeda dibanding
ras kulit putih dengan antihipertensi golongan penyekat EKA, hal ini ditunjang
dengan perbedaan PRA pada kedua kelompok ras ini. Belum terdapat data tentang
respon tekanan darah pasien hipertensi ras melanesiadengan pemberian penyekat
EKA yang ditunjang dengan pemeriksaan kadar PRA pada kelompok ras ini.
Objektif. Menilai apakah terdapat perbedaan respon terapi terhadap penyekat enzim
konversi angiotensin (EKA) pada pasien hipertensi ras melanesia dan ras non
melanesia.
Metode. Penelitian ini adalah penelitian kohort prospektif yangdilakukan di kota
Jayapura bulan September-November 2015terhadap 85 subyek usia 30 sampai 55
tahun dengan hipertensi yang belum pernah diobati sebelumnya. Subyek terbagi atas
2 grup yaitu ras Melanesia (n=34) dan ras Non Melanesia(n=51). Kedua grup tersebut
diberikan lisinopril dosis awal 5 mg. Pemeriksaan tekanan darah dilakukan pada awal
dan diulangi setiap 7 hari selama 4 minggu berturut-turut.
Hasil. Terdapat perbedaan respon tekanan darah pasien hipertensi ras Melanesia dan
ras Non Melanesia. Perbedaan tekanan darah sistolik sebesar 24,5 ± 9,4 mmHg pada
subyek ras Melanesia dan pada subyek Non Melanesia sebesar 34,5 ± 13,5 mmHg
(p<0,001). Perbedaan tekanan darah diastolik subyek ras Melanesia sebesar 13,3±5,5
mmHg dan pada subyek Non Melanesia sebesar 22,6±9,3 mmHg (p<0,001).
Perbedaan tekanan rerata arteri pada subyek ras Melanesia sebesar 17,1±5,6 mmHg
dan pada subek ras Non Melanesia sebesar 26,21±8,8 mmHg (p<0,001). Reratakadar
Plasma Renin Activity (PRA) pada subyek ras Melanesia sebesar 1,48[1,86]
ng/ml/jam dan pada subyek ras Non Melanesia rerata kadar PRA sebesar 1,1[1,47]
ng/ml/jam. Tidak terdapat hubungan yang bermakna rerata kadar PRA pada kedua
kelompok ras ini (p=0,564).
Kesimpulan. Terdapat perbedaan penurunan tekanan darah (sistolik, diastolik dan
tekanan rerata arteri) dengan pemberian penyekat EKA pada kelompok ras Melanesia
dan kelompok ras Non Melanesia dan hal ini tidak berhubungan bermakna dengan
rerata kadar PRA pada kedua kelompok ini sehingga kemungkinan terdapat faktor lain yang mempengaruhi respon penurunan tekanan darah dengan penyekat EKA.ABSTRACT
Hypertension is one of the most commonconditionsin primary health
care that increase mortality and morbidity if it does not receive appropriate therapy.
Several studies show that blacks response differently compared with white in
conjunction with a decrease of blood pressure in response to administer ACE
inhibitor. The studies supported by PRA differences in both group of race. There are
no data ofblood pressure response in hypertensive patientsinMelanesian race by
administeringACE inhibitor supported withPRA levels examination in thisgroup of
race.
Objective. To compare therapeutic response ofangiotensin converting enzyme
blockers (ACE)inhibitorinreducing blood pressure between MelanesianandNon
Melanesian hipertensive patients.
Method. This study is a prospective cohort study conducted in the city of
Jayapura September to November 2015. We found85 subjects aged 30 to 55 years
oldwith hypertensionnever be treated before. Subjects are divided into two
groups, namely the Melanesian race (n = 34) and non Melanesian race (n = 51).
Both groups were given an initial dose of 5 mg of lisinopril. Blood pressure
checks performed at baseline and repeated every 7 days for 4 weeks in a row.
Results. There are differences in the response of blood pressure in hypertensive
patientofMelanesian race and Non Melanesiarace. Reduction ofsystolic blood
pressure of 24.5 ± 9.4 mmHg in subject Melanesian race and on the subject of
Non Melanesian 34.5 ± 13.5 mmHg (p < 0.001). Reduction ofdiastolic blood
pressure of subjectsMelanesians of 13.3 ± 5.5 mmHg, and on the subject of Non
Melanesia 22.6 ± 9.3 mmHg (p<0.001). Reduction ofmean arterial pressure in
subjectMelanesian race at 17.1 ± 5.6 mmHg andNon Melanesian race at 26.21 ±
8.8 mmHg (p < 0.001). Mean Plasma Renin Activity (PRA) on the subject of the
Melanesian race at 1.48 [1.86] ng/ml/h and on the subject of nonMelanesian race
PRA average level of 1.1 [1.47] ng/ml/hr. There was no significant relationship
mean PRA levels in both these racial groups (p = 0.564).
Conclusion. There aredifferences in blood pressure reduction (systolic, diastolic
pressure and mean arterial pressure) with administer of ACE inhibitor in
Melanesianand Non Melanesiagroup of race. There is no significant relation with
averagePRAlevels in both group of race. Another factors affectsresponses of reduction blood pressure with administer ofACEinhibitor may be considered.;Background. Hypertension is one of the most commonconditionsin primary health
care that increase mortality and morbidity if it does not receive appropriate therapy.
Several studies show that blacks response differently compared with white in
conjunction with a decrease of blood pressure in response to administer ACE
inhibitor. The studies supported by PRA differences in both group of race. There are
no data ofblood pressure response in hypertensive patientsinMelanesian race by
administeringACE inhibitor supported withPRA levels examination in thisgroup of
race.
Objective. To compare therapeutic response ofangiotensin converting enzyme
blockers (ACE)inhibitorinreducing blood pressure between MelanesianandNon
Melanesian hipertensive patients.
Method. This study is a prospective cohort study conducted in the city of
Jayapura September to November 2015. We found85 subjects aged 30 to 55 years
oldwith hypertensionnever be treated before. Subjects are divided into two
groups, namely the Melanesian race (n = 34) and non Melanesian race (n = 51).
Both groups were given an initial dose of 5 mg of lisinopril. Blood pressure
checks performed at baseline and repeated every 7 days for 4 weeks in a row.
Results. There are differences in the response of blood pressure in hypertensive
patientofMelanesian race and Non Melanesiarace. Reduction ofsystolic blood
pressure of 24.5 ± 9.4 mmHg in subject Melanesian race and on the subject of
Non Melanesian 34.5 ± 13.5 mmHg (p < 0.001). Reduction ofdiastolic blood
pressure of subjectsMelanesians of 13.3 ± 5.5 mmHg, and on the subject of Non
Melanesia 22.6 ± 9.3 mmHg (p<0.001). Reduction ofmean arterial pressure in
subjectMelanesian race at 17.1 ± 5.6 mmHg andNon Melanesian race at 26.21 ±
8.8 mmHg (p < 0.001). Mean Plasma Renin Activity (PRA) on the subject of the
Melanesian race at 1.48 [1.86] ng/ml/h and on the subject of nonMelanesian race
PRA average level of 1.1 [1.47] ng/ml/hr. There was no significant relationship
mean PRA levels in both these racial groups (p = 0.564).
Conclusion. There aredifferences in blood pressure reduction (systolic, diastolic
pressure and mean arterial pressure) with administer of ACE inhibitor in
Melanesianand Non Melanesiagroup of race. There is no significant relation with
averagePRAlevels in both group of race. Another factors affectsresponses of reduction blood pressure with administer ofACEinhibitor may be considered.;Background. Hypertension is one of the most commonconditionsin primary health
care that increase mortality and morbidity if it does not receive appropriate therapy.
Several studies show that blacks response differently compared with white in
conjunction with a decrease of blood pressure in response to administer ACE
inhibitor. The studies supported by PRA differences in both group of race. There are
no data ofblood pressure response in hypertensive patientsinMelanesian race by
administeringACE inhibitor supported withPRA levels examination in thisgroup of
race.
Objective. To compare therapeutic response ofangiotensin converting enzyme
blockers (ACE)inhibitorinreducing blood pressure between MelanesianandNon
Melanesian hipertensive patients.
Method. This study is a prospective cohort study conducted in the city of
Jayapura September to November 2015. We found85 subjects aged 30 to 55 years
oldwith hypertensionnever be treated before. Subjects are divided into two
groups, namely the Melanesian race (n = 34) and non Melanesian race (n = 51).
Both groups were given an initial dose of 5 mg of lisinopril. Blood pressure
checks performed at baseline and repeated every 7 days for 4 weeks in a row.
Results. There are differences in the response of blood pressure in hypertensive
patientofMelanesian race and Non Melanesiarace. Reduction ofsystolic blood
pressure of 24.5 ± 9.4 mmHg in subject Melanesian race and on the subject of
Non Melanesian 34.5 ± 13.5 mmHg (p < 0.001). Reduction ofdiastolic blood
pressure of subjectsMelanesians of 13.3 ± 5.5 mmHg, and on the subject of Non
Melanesia 22.6 ± 9.3 mmHg (p<0.001). Reduction ofmean arterial pressure in
subjectMelanesian race at 17.1 ± 5.6 mmHg andNon Melanesian race at 26.21 ±
8.8 mmHg (p < 0.001). Mean Plasma Renin Activity (PRA) on the subject of the
Melanesian race at 1.48 [1.86] ng/ml/h and on the subject of nonMelanesian race
PRA average level of 1.1 [1.47] ng/ml/hr. There was no significant relationship
mean PRA levels in both these racial groups (p = 0.564).
Conclusion. There aredifferences in blood pressure reduction (systolic, diastolic
pressure and mean arterial pressure) with administer of ACE inhibitor in
Melanesianand Non Melanesiagroup of race. There is no significant relation with
averagePRAlevels in both group of race. Another factors affectsresponses of reduction blood pressure with administer ofACEinhibitor may be considered."
Fakultas Kedokteran Universitas Indonesia, 2015
SP-PDF
UI - Makalah dan Kertas Kerja  Universitas Indonesia Library
cover
Chorniansyah Indriyanto Rahayu
"ABSTRAK
Latar Belakang : Hipertensi merupakan faktor resiko utama penyakit kardiovaskular,
terutama sindrom koroner akut dan stroke. Peningkatan konsumsi garam berhubungan
dengan kenaikan tekanan darah. Beberapa studi randomized-controlled trial (RCT)
menyatakan bahwa konsumsi rendah garam dapat menurunkan tekanan darah pada
populasi dewasa dengan atau tanpa hipertensi. Variabilitas tekanan darah selama 24 jam
bersifat dinamis. Peningkatan darah nokturnal memiliki makna klinis yang cukup besar,
merupakan salah satu prediktor dari penyebab kerusakan target organ, terutama kejadian
kardiovaskular dan stroke. Asupan garam dapat mempengaruhi variasi tekanan darah 24
jam, yang dalam hal ini dapat juga berpengaruh pada hipertensi nokturnal. Obat penyekat
EKA merupakan obat hipertensi lini pertama yang sering digunakan, terutama pada usia
muda dan hipertensi yang disertai sindrom metabolik, mengingat peranan Sistem Renin
Angiotensin memiliki peranan yang sangat penting dalam patofisiologi hipertensi. Asupan
garam juga memiliki peranan pada patofisiologi terjadinya hipertensi dalam sistem Renin
Angiotensin. Sedikit studi yang meneliti perpaduan obat penyekat EKA dengan asupan
rendah garam dalam menrunkan kejadian hipertensi. Oleh karena itu, Menarik untuk diteliti
pengaruh asupan garam dengan tekanan darah nokturnal pada pasien yang mengkonsumsi
obat penyekat EKA.
Tujuan : Menilai pengaruh asupan garam dengan tekanan darah nokturnal pada pasien
hipertensi yang mendapatkan terapi penyekat EKA.
Metode : Pasien poliklinik berusia 30 ? 50 tahun yang terdiagnosis hipertensi dan belum
pernah mendapatkan anti-hipertensi sebelumnya, dibagi menjadi 2 kelompok (asupan
rendah garam (Na <15 g/hari) dan asupan tinggi garam ≥15 g/hari). Kedua kelompok akan
diberikan lisinopril dan dilakukan pemeriksaan natrium urin 24 jam dan home blood
pressure monitoring..
Hasil Penelitian : Sebanyak 80 pasien hipertensi pasien hipertensi yang belum
mendapatkan terapi diikutsetakan dalam penelitian ini, yang terdiri dari 37 pasien
kelompok rendah garam dan 43 pasien kelompok tinggi garam. Kelompok pasien dengan
asupan rendah garam memliki delta penurunan darah nokturnal sistolik (p<0,001),
diastolic (p<0,001), dan rerata arteri (p<0,001) yang lebih besar dibandingkan pada
kelompok asupan tinggi garam. Rerata asupan garam pada penelitian ini sebesar 16,77
gram/hari. Pada analisa multivariat didapatkan delta penurunan tekanan darah tidak
dipengaruhi oleh usia, jenis kelamin, dislipidemia, IMT, dan durasi tidur.
Kesimpulan : Penelitian ini membuktikan asupan rendah garam dapat mempengaruhi efektivitas terapi penyekat EKA dalam menurunkan tekanan darah nokturnal. ABSTRACT
Background : Hypertension is one of important risk factor of cardiovascular
disease, especially acute coronary syndrome and stroke. High salt intake correlates
to high blood pressure. Some Randomized-Controlled-Trials stated that low salt
intake may decrease blood pressure in adult population with or without
hypertension. Blood pressure variation in 24 hours is not static but dynamically
changes. Increasing nocturnal blood pressure has significantly impacts, and become
one of predictor of target organ damage, especially cardiovascular events and
stroke. Salt intake may interferes both 24 hours blood pressure variation and
nocturnal blood pressure. Angiotensin Converting Enzyme(ACE) Inhibitors is first
drug of choice anti-hypertensive therapy, especially in young age and associated
with metabolic syndrome, due to important role of Renin Angiotensin Aldosterone
System in pathophysiology of hypertension, whereas salt intake also has role in that
system. Only few of studies that had proved combination of ACE Inhibitors and
low salt intake in decreasing blood pressure in hypertension population. Therefore,
it is so important to know the impact of low salt intake to nocturnal blood pressure
in hypertension patient treated with ACE Inhibitors.
Objectives : To know impact of low salt intake to nocturnal blood pressure in
hypertension patient treated with ACE Inhibitors.
Methods : There are 30 ? 50 years old ambulatory patients diagnosed as untreated
hypertension, divided into two groups (low salt intake (Na <15 grams/day) and high
salt intake (≥15 grams/day). Both of groups were administered Lisinopril 10mg and
underwent 24-hours sodium urine collection and home blood pressure monitoring
periodically.
Results : There are 80 ambulatory patients diagnosed as untreated hypertension,
consist of 37 patients in low salt intake group and 43 patients in high salt intake
group. Low salt intake group has lower nocturnal systolic (p<0.001), diastolic
(p<0.001), and mean arterial (p<0.001) blood pressure compared with high salt
intake group. Mean salt intake in this study was 16.77 grams/day. Multivariate
analyzes showed that the difference of decreasing nocturnal blood pressure was not
interfered by age, sex, dyslipidemia, BMI, and sleep duration.
Conclusion : This study has proved that low salt intake may interfere ACE Inhibitors therapy effectiveness in decreasing nocturnal blood pressure.;Background : Hypertension is one of important risk factor of cardiovascular
disease, especially acute coronary syndrome and stroke. High salt intake correlates
to high blood pressure. Some Randomized-Controlled-Trials stated that low salt
intake may decrease blood pressure in adult population with or without
hypertension. Blood pressure variation in 24 hours is not static but dynamically
changes. Increasing nocturnal blood pressure has significantly impacts, and become
one of predictor of target organ damage, especially cardiovascular events and
stroke. Salt intake may interferes both 24 hours blood pressure variation and
nocturnal blood pressure. Angiotensin Converting Enzyme(ACE) Inhibitors is first
drug of choice anti-hypertensive therapy, especially in young age and associated
with metabolic syndrome, due to important role of Renin Angiotensin Aldosterone
System in pathophysiology of hypertension, whereas salt intake also has role in that
system. Only few of studies that had proved combination of ACE Inhibitors and
low salt intake in decreasing blood pressure in hypertension population. Therefore,
it is so important to know the impact of low salt intake to nocturnal blood pressure
in hypertension patient treated with ACE Inhibitors.
Objectives : To know impact of low salt intake to nocturnal blood pressure in
hypertension patient treated with ACE Inhibitors.
Methods : There are 30 ? 50 years old ambulatory patients diagnosed as untreated
hypertension, divided into two groups (low salt intake (Na <15 grams/day) and high
salt intake (≥15 grams/day). Both of groups were administered Lisinopril 10mg and
underwent 24-hours sodium urine collection and home blood pressure monitoring
periodically.
Results : There are 80 ambulatory patients diagnosed as untreated hypertension,
consist of 37 patients in low salt intake group and 43 patients in high salt intake
group. Low salt intake group has lower nocturnal systolic (p<0.001), diastolic
(p<0.001), and mean arterial (p<0.001) blood pressure compared with high salt
intake group. Mean salt intake in this study was 16.77 grams/day. Multivariate
analyzes showed that the difference of decreasing nocturnal blood pressure was not
interfered by age, sex, dyslipidemia, BMI, and sleep duration.
Conclusion : This study has proved that low salt intake may interfere ACE Inhibitors therapy effectiveness in decreasing nocturnal blood pressure.;Background : Hypertension is one of important risk factor of cardiovascular
disease, especially acute coronary syndrome and stroke. High salt intake correlates
to high blood pressure. Some Randomized-Controlled-Trials stated that low salt
intake may decrease blood pressure in adult population with or without
hypertension. Blood pressure variation in 24 hours is not static but dynamically
changes. Increasing nocturnal blood pressure has significantly impacts, and become
one of predictor of target organ damage, especially cardiovascular events and
stroke. Salt intake may interferes both 24 hours blood pressure variation and
nocturnal blood pressure. Angiotensin Converting Enzyme(ACE) Inhibitors is first
drug of choice anti-hypertensive therapy, especially in young age and associated
with metabolic syndrome, due to important role of Renin Angiotensin Aldosterone
System in pathophysiology of hypertension, whereas salt intake also has role in that
system. Only few of studies that had proved combination of ACE Inhibitors and
low salt intake in decreasing blood pressure in hypertension population. Therefore,
it is so important to know the impact of low salt intake to nocturnal blood pressure
in hypertension patient treated with ACE Inhibitors.
Objectives : To know impact of low salt intake to nocturnal blood pressure in
hypertension patient treated with ACE Inhibitors.
Methods : There are 30 ? 50 years old ambulatory patients diagnosed as untreated
hypertension, divided into two groups (low salt intake (Na <15 grams/day) and high
salt intake (≥15 grams/day). Both of groups were administered Lisinopril 10mg and
underwent 24-hours sodium urine collection and home blood pressure monitoring
periodically.
Results : There are 80 ambulatory patients diagnosed as untreated hypertension,
consist of 37 patients in low salt intake group and 43 patients in high salt intake
group. Low salt intake group has lower nocturnal systolic (p<0.001), diastolic
(p<0.001), and mean arterial (p<0.001) blood pressure compared with high salt
intake group. Mean salt intake in this study was 16.77 grams/day. Multivariate
analyzes showed that the difference of decreasing nocturnal blood pressure was not
interfered by age, sex, dyslipidemia, BMI, and sleep duration.
Conclusion : This study has proved that low salt intake may interfere ACE Inhibitors therapy effectiveness in decreasing nocturnal blood pressure."
Fakultas Kedokteran Universitas Indonesia, 2015
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
<<   1 2 3 4 5 6 7 8 9 10   >>